Peak Pharmaceuticals Inc. (PKPH) 0.1273 $PKPH
Peak Pharma Updates Market Positioning and Education of CBD Products
Marketwired - Tue Jun 30, 8:02AM CDT
Peak Pharmaceuticals, Inc. (OTCQB: PKPH) ("Peak Pharma" or the "Company"
, a leading innovator of non-prescription hemp based cannabinoid products, wishes to advise that plans for 2015 summer and fall marketing efforts are underway with a number of initiatives aimed at increasing revenues and growing consumer interest and confidence in its hemp based products.
Peak Pharma Readies New Product Lineup for Canna-Pet(R)
Marketwired - Tue Jun 09, 8:03AM CDT
Peak Pharmaceuticals, Inc. (OTCQB: PKPH) ("Peak Pharma" or the "Company" , a leading innovator of non-prescription hemp based cannabinoid products, and exclusive license holder for Canna-Pet, today announced the development and plans for release and marketing of Canna-Pet(R) Advanced120, a new product targeting small to mid-sized animals.
Peak Pharma Reports Sustained Revenue Growth in Q2 2015
ACCESSWIRE - Wed May 20, 8:16AM CDT
WHITEFISH, MT / ACCESSWIRE / May 20, 2015 / The cannabis industry could reach $35 billion in size by 2020, according to GreenWave Advisors, while pet spending reached nearly $60 billion last year, according to the American Pet Products Association.
HSKA: 29.92 (+0.58), PETS: 18.00 (+0.45), IDXX: 64.09 (+1.22), WOOF: 56.57 (+2.81)
Peak Pharmaceuticals, Inc. Submits 2015 Q2 Financials With Double Digit Revenue Increase
Marketwired - Mon May 18, 11:14AM CDT
Peak Pharmaceuticals, Inc. (OTCQB: PKPH) ("Peak Pharma" or the "Company" , an emerging leader in the research, development, sales and marketing of safe, hemp-based, medicinal products and supplements, today announced results of operations for the three months ending March 31, 2015, which included revenues of $220,932, a healthy 36% increase of over Q1.
Canna-Pet(R) Success Moves Peak Pharmaceuticals Forward
ACCESSWIRE - Tue May 12, 8:16AM CDT
WHITEFISH, MT / ACCESSWIRE / May 12, 2015 / Peak Pharmaceuticals, Inc. (OTCQB: PKPH) and Canna-Pet, a leading innovator of non-prescription hemp based cannabinoid products for animals, announced early in April that an initial trial run of their newly formulated MaxCBD Maple Bacon Biscuits sold out much faster than anticipated. Given the rapid acceptance of the product, it was no surprise that the Company acted quickly to update its online inventory and recently announced that the product is once again available for purchase at www.canna-pet.com.
BTH: 5.61 (+0.03), WFM: 40.80 (-0.07), PETS: 18.00 (+0.45), GNC: 44.16 (+0.10), WOOF: 56.57 (+2.81)
Canna-Pet(R) MaxCBD Dog Biscuits Added to Product Lineup and Available Now
Marketwired - Fri May 01, 8:00AM CDT
Peak Pharmaceuticals, Inc. (OTCQB: PKPH) ("Peak Pharma" or the "Company" , and Canna-Pet, a leading innovator of non-prescription hemp based cannabinoid products for animals, are delighted to announce that MaxCBD Maple Bacon Biscuits for dogs are once again available at its online store at www.canna-pet.com.
Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part VIII
Anthony Cataldo - at Seeking Alpha - Mon Apr 20, 7:25AM CDT
QAI: 29.48 (+0.11)
Peak Pharma Prepares for Human Marketplace as Veterinary Segment Propels Early Commercial Success
ACCESSWIRE - Tue Apr 14, 8:15AM CDT
WHITEFISH, MT / ACCESSWIRE / April 14, 2015 / There's a growing and increasingly vocal body of researchers showing that cannabidiol ("CBD" - the non-psychoactive component of the cannabis plant - could provide substantial health benefits. While GW Pharmaceuticals plc (NASDAQ: GWPH) has pioneered clinical trials in the space, this research suggests that the company is just scratching the surface of what may be possible using natural phytocannabinoids.
VSI: 36.98 (+0.41), AMZN: 443.51 (+9.12), CARA: 13.28 (+0.52), HSKA: 29.92 (+0.58), PETS: 18.00 (+0.45), GWPH: 125.86 (+5.39), GNC: 44.16 (+0.10), WOOF: 56.57 (+2.81)
Peak Pharma and Canna-Pet(R) Enjoy Outstanding Product Launch Success
Marketwired - Mon Apr 13, 8:02AM CDT
Peak Pharmaceuticals, Inc. (OTCQB: PKPH) ("Peak Pharma" or the "Company" , and Canna-Pet, a leading innovator of non-prescription cannabinoid products for animals, were thrilled to announce today that their recent MaxCBD biscuit product launch sold out in under 72 hours.
Canna-Pet(R) Announces Launch of New MaxCBD Canna-Biscuits
Marketwired - Thu Apr 02, 8:01AM CDT
Peak Pharmaceuticals, Inc. (OTCQB: PKPH) (the "Company" , and Canna-Pet, a leading innovator of non-prescription cannabinoid products for animals, are delighted to announce the launch of the all new MaxCBD dog biscuits, which offer up to six times the CBD of the standard Canna-Biscuit product line. The new product is now available online at https://canna-pet.com/product/canna-biscuits-...ple-bacon/.
Canna-Pet(R) Receives Trademark Registration and Launches Dog Biscuits on Amazon Ahead of Schedule
Marketwired - Thu Mar 26, 8:01AM CDT
Peak Pharmaceuticals, Inc. (OTCQB: PKPH) (the "Company" , and Canna-Pet(R), a leading innovator of non-prescription cannabinoid products for animals, announced today they have been advised that the US Patent and Trademark Office has registered the Canna-Pet(R) trademark.
Canna-Pet(TM) Announces Availability on Amazon and April Launch of New MaxCBD Canna-Biscuits
Marketwired - Tue Mar 17, 8:02AM CDT
Peak Pharmaceuticals, Inc. (OTCQB: PKPH) (the "Company" , and Canna-Pet, a leading innovator of over-the-counter cannabinoid products for animals, are pleased to announce the launch of the Canna-Pet(TM) product line on Amazon Services, LLC ("Amazon" and the upcoming release of a newly formulated dog treat to extend the popular Canna-Biscuit product lineup.
53 Marijuana Stocks - A Post-Mortem: Part III And Epilogue
Anthony Cataldo - at Seeking Alpha - Thu Mar 05, 2:25PM CST
VPCO: 1.37 (-0.02)
48 Marijuana Stocks - A Post-Mortem: Part II
Anthony Cataldo - at Seeking Alpha - Wed Mar 04, 7:36AM CST
INSY: 37.53 (+0.49), FULL: 3.56 (+0.05), CARA: 13.28 (+0.52)
Peak Pharmaceuticals Updates Research and Commercial Activities for Q1
Marketwired - Tue Mar 03, 7:55AM CST
Peak Pharmaceuticals, Inc. (OTCQB: PKPH) ("Peak Pharma" or the "Company" , a growth stage company aiming to become a leader in the research, development, sales and marketing of safe, hemp-based supplements for both humans and animals has enjoyed an active beginning to the year and wishes to provide a Q1 2015 update of ongoing research and commercial activities.
12 More Marijuana Stocks To Avoid - Part I
Anthony Cataldo - at Seeking Alpha - Thu Feb 19, 6:21AM CST
XXII: 0.82 (+0.06), VPCO: 1.37 (-0.02)
Peak Pharmaceuticals, Inc. Provides Business Update for the First Quarter of Fiscal 2015
Marketwired - Tue Feb 17, 8:04AM CST
Peak Pharmaceuticals, Inc. (OTCQB: PKPH) ("Peak Pharma" or the "Company" , an emerging leader in the research, development, sales and marketing of safe, hemp-based, medicinal products and supplements, today announced results of operations for the three months ending December 31, 2014, which included revenue of $161,360 and gross profit of $117,338 or 72.7%.
Peak Pharmaceuticals Brings CBD-based Therapies to Pets
ACCESSWIRE - Wed Feb 11, 8:41AM CST
WHITEFISH, MT / ACCESSWIRE / February 11, 2015 / The medical marijuana industry has grown at a 16.2% CAGR between 2009 and 2014 to reach $2 billion in revenue, according to IBISWorld, driven by widespread legalization and promising new data from clinical trials. Some of the non-psychoactive cannabinoids found within the drug - including cannabidiol("CBD" - could prove useful in treating conditions ranging from neurological diseases like Alzheimer's disease to metabolic diseases like diabetes or obesity.
ZTS: 46.96 (+0.39), GWPH: 125.86 (+5.39), PETM: 82.98 (+0.03)
Peak Pharma Updates Market Positioning and Education of CBD Products
Marketwired - Tue Jun 30, 8:02AM CDT
Peak Pharmaceuticals, Inc. (OTCQB: PKPH) ("Peak Pharma" or the "Company"
, a leading innovator of non-prescription hemp based cannabinoid products, wishes to advise that plans for 2015 summer and fall marketing efforts are underway with a number of initiatives aimed at increasing revenues and growing consumer interest and confidence in its hemp based products. Peak Pharma Readies New Product Lineup for Canna-Pet(R)
Marketwired - Tue Jun 09, 8:03AM CDT
Peak Pharmaceuticals, Inc. (OTCQB: PKPH) ("Peak Pharma" or the "Company"
, a leading innovator of non-prescription hemp based cannabinoid products, and exclusive license holder for Canna-Pet, today announced the development and plans for release and marketing of Canna-Pet(R) Advanced120, a new product targeting small to mid-sized animals. Peak Pharma Reports Sustained Revenue Growth in Q2 2015
ACCESSWIRE - Wed May 20, 8:16AM CDT
WHITEFISH, MT / ACCESSWIRE / May 20, 2015 / The cannabis industry could reach $35 billion in size by 2020, according to GreenWave Advisors, while pet spending reached nearly $60 billion last year, according to the American Pet Products Association.
HSKA: 29.92 (+0.58), PETS: 18.00 (+0.45), IDXX: 64.09 (+1.22), WOOF: 56.57 (+2.81)
Peak Pharmaceuticals, Inc. Submits 2015 Q2 Financials With Double Digit Revenue Increase
Marketwired - Mon May 18, 11:14AM CDT
Peak Pharmaceuticals, Inc. (OTCQB: PKPH) ("Peak Pharma" or the "Company"
, an emerging leader in the research, development, sales and marketing of safe, hemp-based, medicinal products and supplements, today announced results of operations for the three months ending March 31, 2015, which included revenues of $220,932, a healthy 36% increase of over Q1. Canna-Pet(R) Success Moves Peak Pharmaceuticals Forward
ACCESSWIRE - Tue May 12, 8:16AM CDT
WHITEFISH, MT / ACCESSWIRE / May 12, 2015 / Peak Pharmaceuticals, Inc. (OTCQB: PKPH) and Canna-Pet, a leading innovator of non-prescription hemp based cannabinoid products for animals, announced early in April that an initial trial run of their newly formulated MaxCBD Maple Bacon Biscuits sold out much faster than anticipated. Given the rapid acceptance of the product, it was no surprise that the Company acted quickly to update its online inventory and recently announced that the product is once again available for purchase at www.canna-pet.com.
BTH: 5.61 (+0.03), WFM: 40.80 (-0.07), PETS: 18.00 (+0.45), GNC: 44.16 (+0.10), WOOF: 56.57 (+2.81)
Canna-Pet(R) MaxCBD Dog Biscuits Added to Product Lineup and Available Now
Marketwired - Fri May 01, 8:00AM CDT
Peak Pharmaceuticals, Inc. (OTCQB: PKPH) ("Peak Pharma" or the "Company"
, and Canna-Pet, a leading innovator of non-prescription hemp based cannabinoid products for animals, are delighted to announce that MaxCBD Maple Bacon Biscuits for dogs are once again available at its online store at www.canna-pet.com. Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part VIII
Anthony Cataldo - at Seeking Alpha - Mon Apr 20, 7:25AM CDT
QAI: 29.48 (+0.11)
Peak Pharma Prepares for Human Marketplace as Veterinary Segment Propels Early Commercial Success
ACCESSWIRE - Tue Apr 14, 8:15AM CDT
WHITEFISH, MT / ACCESSWIRE / April 14, 2015 / There's a growing and increasingly vocal body of researchers showing that cannabidiol ("CBD"
- the non-psychoactive component of the cannabis plant - could provide substantial health benefits. While GW Pharmaceuticals plc (NASDAQ: GWPH) has pioneered clinical trials in the space, this research suggests that the company is just scratching the surface of what may be possible using natural phytocannabinoids. VSI: 36.98 (+0.41), AMZN: 443.51 (+9.12), CARA: 13.28 (+0.52), HSKA: 29.92 (+0.58), PETS: 18.00 (+0.45), GWPH: 125.86 (+5.39), GNC: 44.16 (+0.10), WOOF: 56.57 (+2.81)
Peak Pharma and Canna-Pet(R) Enjoy Outstanding Product Launch Success
Marketwired - Mon Apr 13, 8:02AM CDT
Peak Pharmaceuticals, Inc. (OTCQB: PKPH) ("Peak Pharma" or the "Company"
, and Canna-Pet, a leading innovator of non-prescription cannabinoid products for animals, were thrilled to announce today that their recent MaxCBD biscuit product launch sold out in under 72 hours. Canna-Pet(R) Announces Launch of New MaxCBD Canna-Biscuits
Marketwired - Thu Apr 02, 8:01AM CDT
Peak Pharmaceuticals, Inc. (OTCQB: PKPH) (the "Company"
, and Canna-Pet, a leading innovator of non-prescription cannabinoid products for animals, are delighted to announce the launch of the all new MaxCBD dog biscuits, which offer up to six times the CBD of the standard Canna-Biscuit product line. The new product is now available online at https://canna-pet.com/product/canna-biscuits-...ple-bacon/. Canna-Pet(R) Receives Trademark Registration and Launches Dog Biscuits on Amazon Ahead of Schedule
Marketwired - Thu Mar 26, 8:01AM CDT
Peak Pharmaceuticals, Inc. (OTCQB: PKPH) (the "Company"
, and Canna-Pet(R), a leading innovator of non-prescription cannabinoid products for animals, announced today they have been advised that the US Patent and Trademark Office has registered the Canna-Pet(R) trademark. Canna-Pet(TM) Announces Availability on Amazon and April Launch of New MaxCBD Canna-Biscuits
Marketwired - Tue Mar 17, 8:02AM CDT
Peak Pharmaceuticals, Inc. (OTCQB: PKPH) (the "Company"
, and Canna-Pet, a leading innovator of over-the-counter cannabinoid products for animals, are pleased to announce the launch of the Canna-Pet(TM) product line on Amazon Services, LLC ("Amazon" and the upcoming release of a newly formulated dog treat to extend the popular Canna-Biscuit product lineup. 53 Marijuana Stocks - A Post-Mortem: Part III And Epilogue
Anthony Cataldo - at Seeking Alpha - Thu Mar 05, 2:25PM CST
VPCO: 1.37 (-0.02)
48 Marijuana Stocks - A Post-Mortem: Part II
Anthony Cataldo - at Seeking Alpha - Wed Mar 04, 7:36AM CST
INSY: 37.53 (+0.49), FULL: 3.56 (+0.05), CARA: 13.28 (+0.52)
Peak Pharmaceuticals Updates Research and Commercial Activities for Q1
Marketwired - Tue Mar 03, 7:55AM CST
Peak Pharmaceuticals, Inc. (OTCQB: PKPH) ("Peak Pharma" or the "Company"
, a growth stage company aiming to become a leader in the research, development, sales and marketing of safe, hemp-based supplements for both humans and animals has enjoyed an active beginning to the year and wishes to provide a Q1 2015 update of ongoing research and commercial activities. 12 More Marijuana Stocks To Avoid - Part I
Anthony Cataldo - at Seeking Alpha - Thu Feb 19, 6:21AM CST
XXII: 0.82 (+0.06), VPCO: 1.37 (-0.02)
Peak Pharmaceuticals, Inc. Provides Business Update for the First Quarter of Fiscal 2015
Marketwired - Tue Feb 17, 8:04AM CST
Peak Pharmaceuticals, Inc. (OTCQB: PKPH) ("Peak Pharma" or the "Company"
, an emerging leader in the research, development, sales and marketing of safe, hemp-based, medicinal products and supplements, today announced results of operations for the three months ending December 31, 2014, which included revenue of $161,360 and gross profit of $117,338 or 72.7%. Peak Pharmaceuticals Brings CBD-based Therapies to Pets
ACCESSWIRE - Wed Feb 11, 8:41AM CST
WHITEFISH, MT / ACCESSWIRE / February 11, 2015 / The medical marijuana industry has grown at a 16.2% CAGR between 2009 and 2014 to reach $2 billion in revenue, according to IBISWorld, driven by widespread legalization and promising new data from clinical trials. Some of the non-psychoactive cannabinoids found within the drug - including cannabidiol("CBD"
- could prove useful in treating conditions ranging from neurological diseases like Alzheimer's disease to metabolic diseases like diabetes or obesity. ZTS: 46.96 (+0.39), GWPH: 125.86 (+5.39), PETM: 82.98 (+0.03)
